CHRS Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $1.99 = $19.9
CHRS Charts
CHRS Prices
View the CHRS historical prices.
52WL $1.43
The 52 Week Low is $1.43 set on Fri, Nov 10, 2023.
52WH $8.33
The 52 Week High is $8.33 set on Fri, Apr 21, 2023. The current price, $1.99, is 0% below the 52 Week High.
ATH $38.10
The All-Time High is $38.10 set on Wed, Jul 22, 2015. The current price, $1.99, is 0% below the All Time High.
52 Week Range
CHRS Dividends
CHRS has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
CHRS Profile
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
